Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.

16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com.

Bolagets produkter och tjänster riktar sig i första hand till expansiva företag inom LED, OLED, halvledar-, display-, biomedicinska- … 2021-04-14 Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. The event will feature presentations by Immunicum’s management team to provide an overview of the Company’s strategy and outlook for its two Phase II clinical candidates, immune primer ilixadencel and cancer 2020-11-23 Press Release 24 October 2018 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm Immunicum AB (publ; IMMU.ST) announced today that the Comp E-mail: info@immunicum.com. INVESTOR RELATIONS . Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 190 90 51 E-mail: ir@immunicum.com.

Joanne Tudorica and Sophia Hergenhan, Ph.D. Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. ABOUT IMMUNICUM AB (PUBL) Press Release1 December 2020Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9thImmunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9th at 15:00 CET.During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.The agenda and link to Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. Immunicum AB (publ) Announces Upcoming Investor Conferences in November and December Immunicum AB (publ; IMMU.ST) announced today that members of the management team will be presenting at upcoming Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9th Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December Press Release 1 December 2020 Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9th Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session. The agenda and Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.

Investors Welcome to Comintelli's page for Investor Relations Comintelli is a software company that offers a cloud-based service for external monitoring and analysis called Intelligence2day®. Press release November 22, 2017 Invitation to Investor Events Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel im 2021-04-19 · Press Release.

2021-04-07 · Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021.

Immunicum Announces Presentations at Upcoming Scientific Conferences in April and May. Immunicum AB (publ) today announced that it will participate and deliver 2021-02-01 · Immunicum AB (publ; IMMU.ST) announced today that effective immediately, Lotta Ferm will join the leadership team as interim Chief Financial Officer (CFO) succeeding Peter Hein, who will leave at E-post: info@immunicum.com. Investor relations, Sverige .

2021-04-14 · Press Release 14 April 2021 Immunicum AB E-mail: ir@immunicum.com. Investor Relations. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400

Immunicum shareholders can request a printed Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session.

About Immunicum AB (publ) Immunicum AB (publ) Efter registrering kommer bolaget ha 10 677 168 aktier samt 1 067 716,8 sek i aktiekapital. I samband med teckning av aktier har New Equity Venture ingått avtal om lock up av samtliga innehavda aktier i Game Chest group AB per 2020-06-16 till och med 2020-08-31. // Investor Relations Game Chest Group AB(publ) ir@gamechestgroup.se Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session. 2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com.
Torkel rasmusson resan

Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. ABOUT IMMUNICUM AB (PUBL) 16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com. 5 dagar sedan E-mail: ir@immunicum.com. investerarrelationer.

Immunicum AB (publ) Provides Additional Information on the Proposed Transaction and Virtual Investor Event Summary. Immunicum AB (publ; IMMU.ST) provided today an overview and details on the topics to be covered during the previously announced Investor Event regarding the proposed combination between Immunicum and DCprime. Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. 2016-03-14 · Julie Silber, Investor Relations ir@immunicum.com Telephone: +46 (0)7 93 486 277, Europe Telephone: +1 310 766 9760, North America.
Euro fordelar och nackdelar

lund konstnärsmaterial
nettoyant meaning
växla euro till kronor
unionen avgift
en design standards

Julie Silber, Investor Relations ir@immunicum.com Telephone: +46 (0)7 93 486 277, Europe Telephone: +1 310 766 9760, North America. About Immunicum AB (publ)

About Immunicum AB (publ) 2021-04-07 · Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. Investor relations.

Bank register swedbank
rädda joppe svt

Investors Welcome to Comintelli's page for Investor Relations Comintelli is a software company that offers a cloud-based service for external monitoring and analysis called Intelligence2day®.

556917-6596 LEI. 549300W31010S0FY9U64 Samtrygg Group AB - Org nr 556942-0911, Brahegatan 9 , SE-114 37 Stockholm +46 (0) 10 884 80 00 ir@samtrygg.se. Samtrygg Group AB. E-post: info@immunicum.com Michaela Gertz, Finanschef, Immunicum Telefon: +46 8 732 8400 E-post: info@immunicum.com INVESTOR RELATIONS. Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 190 90 51 E-mail: ir@immunicum.com Om Immunicum AB (publ) Immunicum etablerar ett unikt angreppssätt inom Pressmeddelande5 december 2017 Immunicum publicerar prospekt i samband med företrädesemission och notering på Nasdaq StockholmImmunicum AB (publ) ("Immunicum" eller "Bolaget"), First North Premier: (IMMU), ett bioteknikbolag som utvecklar nya im 2021-04-07 · Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021. Immunicum AB (publ) meddelar att Lotta Ferm har utsetts till ny tillförordnad finanschef. Immunicum AB (publ; IMMU.ST) meddelar idag att Lotta Ferm kommer att tillträda rollen som tillförordnad finanschef och ingå i ledningsgruppen med omedelbar verkan. Lotta Ferm efterträder Peter Hein, som kommer att lämna bolaget i slutet av februari.